Navigation Links
In Age of Patent Expiration, Planning Groups for New Pharma Products Growing in Importance

CHAPEL HILL, N.C., March 9, 2013 /PRNewswire/ -- New product launch groups in the bio-pharmaceutical industry are often faced with dueling pressures of efficiently developing new products with minimum risk and maximum value. In addition, new product commercialization efforts have taken on increased importance in recent years. With the expiration of patents becoming a looming concern across the biopharma industry, individual companies must now, more than ever, find a way to effectively develop new products in a timely manner.

To address various issues related to the critical elements of the new product planning (NPP) function in bio-pharma companies, Best Practices, LLC completed a benchmarking study. The report, "Pharmaceutical New Product Planning: Structure and Activities to Drive Growth and Profitability," addresses the critical roles and structure of NPP groups.

The report provides professionals with actionable insights into critical aspects of the NPP function, such as coordinating regional and global efforts and carrying out dozens of activities that generate commercial insights. Other key study topics include:

  • Benchmarks of NPP group structures, roles, responsibilities, and attributes
  • Assessments of the levers of impact and  effectiveness
  • Definitions of interactions and optimal working relationships between Regional and Global NPP groups
  • Discoveries surrounding the full set of activities NPP groups perform, their timing, intended outcomes, and value for the organization
  • Insights into the future of the NPP function

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from over a dozen of the participating companies.

In addition, Best Practices has found that the role of the NPP function has expanded and has continued to change in recent years. In order to expand upon previous research and benchmarks, Best Practices recently launched a new study that focuses on the importance of the NPP function in the biopharmaceutical industry.

To participate in the online survey, follow this link:

To download a complimentary excerpt from the initial report, go to:

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or visit our website at


Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.




SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. OrbusNeich File Patent Infringement Lawsuit Against Boston Scientific in Ireland
2. Amedica Expands Patent Portfolio with Proprietary Silicon Nitride Total Disc Implant to Treat Neck and Back Pain
3. BioElectronics Announces Publication of Patent Application
4. OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands
5. Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
6. Terumo Medical Corporation Files Patent Infringement Lawsuit Against Vascular Solutions And Lepu Medical Technology Company
7. High Profile HealthCare Companies: Leading Pharma Company Secures New Patents
8. Rosetta Genomics Receives Two Key U.S. Patent Allowances
9. Immunotech Laboratories Receives $2M Funding Approval To Begin European Clinical Trials Testing For Companys Patented "IPF" HIV-AIDS Medicines
10. Japan Biosimilars - ¥200b Worth of Biologic Products Going Off Patent by 2015
11. OrbusNeich Announces Favorable Ruling From the European Patent Office
Post Your Comments:
(Date:11/27/2015)... , Pays-Bas, November 27, 2015 ... l,immunothérapie au traitement photodynamique au Bremachlorin contre le ... nouvelle approche consistant à combiner l,immunothérapie au traitement ...    --> Une nouvelle approche ... Bremachlorin contre le cancer avancé.    ...
(Date:11/27/2015)... , November 27, 2015 ... set to go online. The potential to save costs, ... vast and far from fully exploited as yet. Here, ... health records, either via mobile tablet or directly at ... --> ) -->      ...
(Date:11/27/2015)... , Niederlande, November 27, 2015 ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... bei fortgeschrittenem Krebs.   --> ... bei fortgeschrittenem Krebs.   Clinical Cancer ... --> Clinical Cancer Research vom 6. ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed at which ... age, more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions ... overworked. The forgotten part of this equation: 80 percent of medical care occurs ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a ... customers 10% off of their purchase of lice treatment product. In addition, customers will ... to a company spokesperson. “Finding lice is a sure way to ruin the holidays, ...
(Date:11/27/2015)... Fairfax, VVA (PRWEB) , ... November 27, 2015 ... ... (RBMA) motto of progress through sharing, the 2016 Building Better Radiology ... campaigns. The conference will begin on Sunday, March 6, 2016, at Caesars Palace ...
(Date:11/27/2015)... ... 27, 2015 , ... Keeping in mind challenges faced by ... wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for ... parents and bring advice from parenting experts within their reach. As a part ...
(Date:11/27/2015)... ... 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces ... This is one of Joplin's most famous and beautiful concert posters. The concert was ... in Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's ...
Breaking Medicine News(10 mins):